drugset / Trial / NCT03203070

Laparoscopic-guided TAP Block in Patients Undergoing Gastric Bypass

NCT03203070

Phase 3 Unknown 200 enrolled Hospital General Universitario Elche
RandomizedParallel-groupDouble-blindPrevention

Summary

A prospective randomized trial will be performed. Patients undergoing gastric bypass will be randomized into 2 groups: patients undergoing laparoscopic-guided transversus abdominis plane (TAP) block as part of multimodal analgesia (Group 1), associated with postoperative intravenous analgesia, and patients receiving only postoperative intravenous analgesia (Group 2). Postoperative pain will be assessed with a Visual Analogic Scale 24h after surgery and morphine needs will be quantified.

Timeline

Start
2017-03-01
Primary completion
2017-09
Completion
2017-09

Drugs

EvaluationDrugModalityDoseRoute
Background dipyrone Unknown 2 g Intravenous

Indications